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Abstract
Background: The prevalence of  Diabetes mellitus (DM) is on a rise in sub-Saharan Africa and will more than double by 
2025. Cardiovascular disease (CVD) accounts for up to 2/3 of  all deaths in the diabetic population. Of  all the CVD deaths 
in DM, 3/4 occur in sub Saharan Africa (SSA). Non invasive identification of  cardiac abnormalities, such as Left Ventricular 
Hypertrophy (LVH), diastolic and systolic dysfunction, is not part of  diabetes complications surveillance programs in Ugan-
da and there is limited data on this problem. This study sought to determine the prevalence, types and factors associated with 
echocardiographic abnormalities among newly diagnosed diabetic patients at Mulago National referral hospital in Uganda.
Methods: In this cross sectional study conducted between June 2014 and December 2014, we recruited 202 newly diag-
nosed adult diabetic patients. Information on patients' socio-demographics, bio-physical profile, biochemical testing and 
echocardiographic findings was obtained for all the participants using a pre-tested questionnaire. An abnormal echocardio-
gram in this study was defined as the presence of  LVH, diastolic and/or systolic dysfunction and wall motion abnormality. 
Bivariate and multivariate logistic regression analyses were used to investigate the association of  several parameters with 
echocardiographic abnormalities.
Results: Of  the 202 patients recruited, males were 102(50.5%) and the mean age was 46±15 years. Majority of  patients 
had type 2 DM, 156(77.2%) and type 1 DM, 41(20.3%) with mean HbA1C of  13.9±5.3%. Mean duration of  diabetes was 
2 months. The prevalence of  an abnormal echocardiogram was 67.8 % (95% CI 60%-74%). Diastolic dysfunction, systolic 
dysfunction, LVH and wall motion abnormalities were present in 55.0%, 21.8%, 19.3% and 4.0% of  all the participants 
respectively. In bivariate logistic regression analysis, the factors associated with an abnormal echocardiogram were age (OR 
1.09 [95% CI 1.06–1.12], P <0.0001), type 2 DM (OR 5.8[95% CI 2.77-12.07], P<0.0001), hypertension (OR 2.64[95% CI 
1.44-4.85], P=0.002), obesity (OR 3.51[955 CI 1.25-9.84], P=0.017 and increased waist circumference (OR 1.02[95% CI 
1.00-1.04], P=0.024. On Multiple logistic regression analysis, age was the only factor associated with an abnormal echocar-
diogram (OR 1.09[95%CI 1.05-1.15], P<0.0001).
Conclusion: Echocardiographic abnormalities were common among newly diagnosed adults with DM. Traditional CVD 
risk factors were associated with an abnormal echocardiogram in this patient population. Due to a high prevalence of  
echocardiographic abnormalities among newly diagnosed diabetics, we recommend screening for cardiac disease especially 
in patients who present with traditional CVD risk factors. This will facilitate early diagnosis, management and hence better 
patient outcomes.                                                                                                   
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Introduction
Diabetes is an important cause of  mortality and mor-
bidity worldwide1. The worldwide prevalence of  diabe-
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tes mellitus (DM) has risen dramatically over the past 
2 decades2. The global number of  individuals with dia-
betes in 2000 was estimated to be 171 million (2.8% of  
the world’s population), a figure projected to increase in 
2030 to 366 million (6.5%), 298 million of  whom will 
live in developing countries3. Type 2 diabetes and its 
associated long-term complications continue to acceler-
ate among patients who reside in developing countries 
due to rapidly increasing life expectancy at birth4. The 
estimated prevalence of  diabetes in Africa is 1% in rural 
areas, up to 5% to 7% in urban sub Saharan Africa, and 
183
between 8% and 13% in more developed areas such as 
South Africa and in populations of  Indian origin5.
An aging population together with rapid urbanization 
will lead to an increase in the prevalence of  diabetes by 
the year 20256 at which time the majority of  the world’s 
diabetespopulation will be living in the developing 
countries7. By the year 2025, the prevalence of  diabetes 
in sub-Saharan Africa is expected to more than double 
the current figures (3).
 
Cardiovascular diseases, the commonest cause of  death 
in patients with diabetes, accounts for up to two-thirds 
of  all deaths in this group5. The risk of  heart disease 
in diabetes is increased up to 15 years prior to the di-
agnosis of  diabetes8. Management of  established CVD 
in these SSA countries is unrewarding due to chronic 
shortage of  resources. Early diagnosis of  preclinical 
CVD in this patient population is therefore a priority as 
it will enable early intervention to prevent or delay com-
plications. Subclinical cardiac abnormalities of  struc-
ture and function, detectable using myocardial Tissue 
Doppler Imaging (TDI) and conventional echocardio-
graphic imaging are common in adults with diabetes9. 
With increasing availability of  this non-invasive cardiac 
ultrasound service including point-of-care hand-held 
echocardiographic machines, it is reasonable to argue 
that echo screening in all diabetes be part of  routine 
care.
 
The absence of  systematically collected data on 
pre-clinical CVD in these patients makes it impossible 
to implement policy change as suggested above as no 
studies have been carried out to assess the magnitude 
of  the problem in this patient group.
 
Accordingly, the aim of  this study was to determine the 
prevalence, types and factors associated with echocardi-
ographic abnormalities among newly diagnosed diabet-
ic patients at Mulago hospital.
Methods
Study design
This was a cross-sectional study among 202 newly di-
agnosed diabetic patients at Mulago National referral 
hospital in Uganda conducted from June to December 
2014. The study was carried out in the diabetic outpa-
tient clinic and the medical wards; 4B endocrine and 
3BEM of  Mulago National referral Hospital. Mulago 
serves as the National referral hospital for Uganda and 
Teaching Hospital for Makerere University with a bed 
capacity of  1500. A diagnosis of  DM was made by one 
of  the following: Fasting glucose >126mg/dL, 2 hour 
plasma glucose of  >200mg/dl after oral Glucose tol-
erance test (OGTT), or glycated hemoglobin (HbA1C) 
>6.5%. We differentiated type 1 from type 2 DM using 
clinical assessment because we were unable to assess in-
sulin levels which is the gold standard. Blood pressure 
was measured using a mercury sphygmomanometer and 
an average of  the 2 readings was used in the analysis.
Hypertension was defined as present if  subjects were 
on anti-hypertensive medication, had history of  hyper-
tension and/or evidence of  hypertension (blood pres-
sure ≥140/90 mmHg).
All newly diagnosed diabetic patients aged 18 years 
and above attending the diabetic clinic or admitted to 
the medical wards of  Mulago hospital during the study 
period who met the inclusion criteria and provided in-
formed consent were recruited consecutively. Using 
prevalence of   72% for an abnormal echocardiogram 
among diabetics as determined by Piyush10, a sample 
size of   309 was estimated using the Kish Leslie (1965) 
formula11. However we were unable to achieve the re-




Type1 DM: This referred to patients who required in-
sulin and were depending on insulin for glucose control 
since diagnosis.
Type 2 DM: Patients were classified as having type 
2 diabetes mellitus if  they required oral hypoglycemic 
agents or usage of  combination of  insulin and the oral 
hypoglycemic agents for glucose control.
Type 3 DM is diabetes secondary to an identifiable 
cause like pancreatitis or cancer of  the pancreas.
Type 4 DM is gestational diabetes.
Fig. 1 illustrates the patient recruitment flow.
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The following study parameters were collected using a 
pre tested questionnaire: patients’ demographic data, 
history of  hypertension, age, physical exercise, marital 
status, date of  diagnosis of  DM, drug history, occu-
pation, education level, LNMP, Blood pressure, body 
Weight, height, Waist and hip circumferences. Glycat-
ed haemoglobin (HbA1C) was measured by automat-
ed high performance liquid chromatography. Other 
investigations included urinalysis and Microalbuminu-
ria using ACR. Echocardiography parameters were ac-
quired using a commercially available machine, Phillips 
HD11XE (Eindhoven, The Netherlands) with 2-D, M 
Mode and Doppler capabilities was used according to 
the American Society of  Echocardiography12.
 
Ethics approval
The study was approved by the School of  Medicine Re-
search and Ethics Committee of  the College of  Health 
Sciences, Makerere University. Written informed con-
sent for involvement in the study was obtained from 
the study participants. Enrolment was totally free and 
voluntary and participants were free to withdraw at any 
time without any consequences to them. The patients’ 
records/information was anonymized and de-identified 
prior to analysis.
 
Data management and analysis
Data was captured on hard copy Case Report Forms, 
then transferred to the electronic EPIDATA version 
3.1 and exported to STATA 13 for analysis. Continuous 
variables were summarized as mean (± standard devia-
tion), median (± inter quartile range) and presented in 
tables. Categorical data was summarized using frequen-
cy and percentages and results are presented in frequen-
cy tables and bar charts. Logistic regression was used 
to determine odds for a given outcome and presented 
as Odds ratio (OR) and their 95% confidence interval 
(CI). Only factors with P- value <0.2 at bivariate anal-
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ysis were considered for multivariate analysis. Multivar-
iate logistic regression was used to determine factors 
associated with an abnormal echocardiogram and the 
different echo abnormalities (secondary outcomes): sig-
nificance was at 5%.
 
Results
This study recruited 202 newly diagnosed diabetic pa-
tients between May 2014 and January 2015. Of  these, 
102(50.5%) were males. The mean age of  the partici-
pants was 46 years (18-90). Majority of  patients had type 
2 DM, 156 (77.2%) or type 1 DM, 41 (20.3%). None of  
the patients had type 3 DM, and the remainder had ges-
tational DM, 5 (2.5%). The mean HbA1C was 13.9%, 
(SD: 5.27%). Mean duration of  diabetes was 2 months. 
Majority of  patients 128 (63.6%) were unemployed. 
The education levels of  participants were mainly prima-
ry which accounted for 78 (38.6%). The remainder of  
patients had had either secondary education 75 (37.1%), 
tertiary education 31 (15.4%), or no formal education 
at all 18 (8.9%). Majority of  the study participants 118 
(58.4%) were married. Study participants who had nev-
er been married were 30 (14.9%) while those who were 
once married and no longer married were 54(26.7%). 
Of  all the participants, 125(61.95%) had hypertension 
according to the operational definition and only 38.1% 
were normotensive.
Table 1. Characteristics of newly diagnosed diabetic patients at Mulago National 











Gender Male 102  50.5  63 46.0 
Female          100 49.5 74 54.0 
Employment Employed 74  36.4 50 36.5 
Unemployed 128 63.6 87 63.5 
Pregnancy Yes 5  5.0  2 2.7 
No 95 95.0 72 93.3 
Education None 18  8.9  17 12.4 
Primary 78 38.6 50 36.5 
Secondary 75 37.1 49 35.8 
Tertiary 31 15.4 21 15.3 
Marital status Never married 30   14.9  14 10.2 
Currently 
married 
118 58.4 84 61.3 
No longer 
married 
54 26.7 39 28.5 
DM type Type 1  41  20.3 15 10.9 
Type 2 156 77.2 120 87.6 
Secondary 0 0.0 0.0 0.0 
Gestational 5 2.5 2 1.5 
BP status Normotensive 77 38.1 42 30.7 
Hypertensive 125 61.9 95 69.3 
Microalbumin 
In urine 
Absent 79 44.9 52 44.1 
Present 97 55.1 66 55.9 
BMI Underweight 40 19.8 22 16.1 
Normal weight 76 37.6 49 35.8 
Over weight 49 24.3 36 26.3 
Obesity 37 18.3 30 21.9 
Waist 
circumference 
Normal 121 59.9 84 66.7 
Abnormal 81 40.1 42 33.3 
Waist hip 
ratio 
Normal 141 69.8 92 67.2 
Abnormal 61 30.2 45 32.9 
HbA1C Normal 15 8.4 11 9.2 
Abnormal 164 91.6 109 90.8 
Drugs ACEI/ARBS 19 33.9 19 41.3 
CCB 15 26.8 13 28.3 
Diuretics 3 5.4 3 6.5 
Beta blockers 5 8.9 4 8.7 
Not on drugs 30 55.6 21 47.7 
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Echocardiographic abnormalities.
Transthoracic echocardiography was performed on all 
202 participants and the results are shown in Table 2. 
Prevalence of  an abnormal echocardiogram was 67.8 
% (95% CI: 60%-74%). Isolated Diastolic dysfunction 
was present in 55.0% of  all the participants (95%CI: 
Table 2. Comparison of characteristics for hypertensive and normotensive patients who 
participated in the study (N=202). 
 
Employment Employed      76 38.0 41(53.9)    35(46.05) 
Unemployed     124 62.00 85(68.6)    39(31.45) 
Pregnancy Yes     6 5.41 3(50.0)   3(50.00) 
No    105 94.59 74(70.5)   31(29.52) 
Education None    17 8.46 10(58.8)   7(41.18) 
Primary    78 38.81 50(64.1)   28(35.90) 
Secondary    75 37.31 45(60.0)   30(40.00) 
Tertiary    31 15.42 21(67.7)   10(32.26) 
Marital status Never married   29 14.43 7(24.1)   22(75.86) 
Currently 
married 
 119 59.20 83(69.8)   36(30.25) 
No longer 
married 
  53 26.4 36(67.9)   17(32.1) 
 





Age <40 years 58 28.86 21(36.2) 37(63.8) 
>40 years 143 71.14 105(73.4) 38(26.6) 
Gender Male 102 50.75 54(52.9) 48(47.06) 
Female 99 49.25 72(72.7) 27(27.27) 
47.8%-61.9%) while isolated systolic dysfunction was 
present in 21.8 %( 95% CI: 16.3%-28.1%) of  all the 
participants. The prevalence of  combined systolic and 
diastolic dysfunction was 13 (95% CI:8.9%-18.85). Left 
ventricular hypertrophy (LVH) and wall motion abnor-
mality accounted for 19.3 %( 95%CI 14.1%-25.4%) and 
4 %(95%CI 1.7%-7.6%) respectively.
Table 3.Prevalence of echocardiographic abnormalities among newly diagnosed diabetic 
patients at Mulago hospital (N=202). 
 
Characteristic Normal Abnormal CI (95%) 
Echocardiogram 65(32.2) 137(67.8) (60.0-74.0) 
Isolated Diastolic function 91(45.0) 111(55.0) (47.8-61.9) 
Isolated Systolic function 158(78.2) 44(21.8) (16.3-28.1) 
Combined systolic and diastolic function 175(86.6) 27(13.4) (8.9-18.8) 
Left ventricular hypertrophy 163(80.7) 39(19.3) (14.1-25.4) 
Wall motion 194(96.0) 8(4.0) (1.7-7.6) 
     * Note: CI= Confidence Interval 
Echocardiographic Abnormalities and Type of  
DM.
Generally, the prevalence of  the different echocardio-
graphic abnormalities was much higher among patients 
with type 2 compared to type 1 DM (Figure 2). Of  these 
echocardiographic abnormalities 120 (87.6%) were seen 
among type 2 Diabetics while type 1 DM accounted for 
15 (11.0%). Wall motion abnormalities were only pres-
ent among type 2 DM patients; there were no patients 
with type 1 DM with wall motion abnormalities (Figure 
2).
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Factors associated with an abnormal echocardio-
gram.
In bivariate analysis, the factors associated with an ab-
normal echocardiogram included: age (P<0.0001), hy-
pertension (P=0.002), obesity (P=0.017) and increase 
in waist circumference (P=0.024).
After adjusting for patients’ sex, hypertension, BMI, 
waist hip ratio and waist circumference the only signif-
icant factor associated with an abnormal echocardio-
gram was age (OR1.09 [1.05-1.15] P<0.0001). Hyper-
tension, obesity, waist hip ratio and waist circumference 
were no longer significantly associated with an abnor-
mal echocardiogram in this model.
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Table 4.Logistic regression for factors associated with an abnormal echocardiogram 
among newly diagnosed diabetic patients at Mulago hospital. 
  











Male 39(60.0) 63(46.0) 1       










HbA1C Normal 4(6.78) 11(9.2) 1       
Abnormal 55(93.2) 109(90.8) 0.72(0.22-
2.37) 
0.589     
BP status Normotensive 35(53.9) 42(30.7) 1       





Microalbuminuria Normal 27(46.6) 52(44.1) 1       
Abnormal 31(53.5) 66(55.9) 1.11(0.59-
2.08) 
0.756     
BMI Underweight 18(27.7) 22(16.1) 1       




















Waist circumference   1.02(1.00-
1.04) 
0.024     
* Note: OR= Odds ratio, CI= Confidence Interval 
Some figures may not sum to total due to missing data. 
Adjusted for sex, hypertension, BMI and waist hip ratio. 
Discussion
Prevalence of  echocardiographic abnormalities 
among newly diagnosed diabetic patients.
Abnormal echocardiogram (Generally).
The prevalence of  an abnormal echocardiogram as de-
fined in this study was 67.8% among newly diagnosed 
diabetic patients of  whom 77.2% had type 2 DM. Of  
these echocardiographic abnormalities 120 (87.6%) 
were seen among type 2 Diabetics while type 1 DM 
accounted for 15 (11.0%). Diastolic dysfunction was 
present in 55% of  all participants while LVH and sys-
tolic dysfunction were present in 19.3% and 21.8% re-
spectively. Only 4% of  all participants had regional wall 
motion abnormality.
Our findings are in tandem with evidence from earlier 
studies, which revealed that: the main forms of  struc-
tural heart disease associated with DM are coronary 
heart disease and diabetic cardiomyopathy, which is 
characterized by LV hypertrophy, LV diastolic and sys-
tolic dysfunction13.
These findings are comparable to what was found in 
a cohort study among 229 type 2 diabetic patients in 
Australia performed in 200810.  An abnormal echocar-
diogram was present in 166 (72%) of  all patients. In this 
study diastolic dysfunction alone was present in 109(48 
%) of  all patients10, similar to other studies.
Unlike type 1 DM, type 2DM may have a latent peri-
od before diagnosis which can go up to 10 years and 
patients may only be diagnosed with a complication. 
This may explain why majority of  the newly diagnosed 
type 2 diabetics presented with an abnormal echocardi-
ogram in our study.
Type 1 DM patients in our study had a very low prev-
alence of  echocardiographic abnormalities; abnormal 
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echocardiogram was present in only 15 (11.0 %) of  all 
patients.
Our findings are different from what Bryan et al found; 
their study  assessed 141 type 1 diabetic patients and 
found the prevalence to be 2.5 times higher than what 
we found. The major abnormalities on the echocardio-
gram was  diastolic dysfunction,  LVH and systolic dys-
function14. The difference in the studies is that the latter 
looked at patients with an average duration of  diabetes 
of  21 years and only type 1 DM, yet in our study we 
enrolled only newly diagnosed diabetics with mean du-
ration of  DM of  only 2 months.
 
Diastolic dysfunction
In Africa, Diabetes-related cardiovascular disease com-
plications were considered to be rare but are on the 
rise5. We found the prevalence of  LVDD to be 55% in 
our study. This is in keeping with earlier studies in Afri-
ca which showed  that Diabetic cardiomyopathy, which 
is largely represented by diastolic dysfunction, may af-
fect up to 50% of  all patients5.
Over the last three decades several studies have demon-
strated the presence of  left ventricular (LV) diastolic 
dysfunction in patients with normal LV ejection frac-
tion (LVEF)10,14-17. Majority of  these studies have found 
a high prevalence of  Left ventricular diastolic dysfunc-
tion ranging from 40% to 75%10,14-16,18.
The  prevalence of  LVDD in patients with T2DM has 
been shown to vary from 25% to 60% in different stud-
ies19-21.   It is noted that majority of  patients in our study 
had type 2 DM and were newly diagnosed as cited ear-
lier. This could account for the similarity in the results. 
In Senegal LVDD has been found in 62% of  type 2 
DM patients22.
Prior to the development of  symptomatic heart failure, 
subclinical LV dysfunction (systolic and diastolic) may 
exist for some time and are associated with a poor prog-
nosis13,15.
We used mitral E/A ratio to define diastolic dysfunc-
tion unlike in the studies quoted where they used  both 
E/A and TDI for diastolic dysfunction a method that 
increases the sensitivity in diagnosis. We used mitral 
E/A because it is the standard of  care in our setting 
and TDI has not been widely used. This means that 
the prevalence of  diastolic dysfunction we reported of  
55% among newly diagnosed diabetics may be an under 
estimate of  a bigger problem.
Omission of  TDI may eliminate up to 25% of  patients 
with pseudonormalization which may go unmasked10. 
This may call for longitudinal studies to evaluate this 
problem further using TDI.
The clinical implication of  this diastolic dysfunction 
which was found in majority of  our patients is the inev-
itable progression to clinical heart failure. In fact Pro-
gression of  diastolic dysfunction to heart failure is 4 
years in type 2 DM9,10 and 6 years in type 1 DM14. There 
is great need to follow up these patients before overt 
clinical outcomes occur.
 
Left ventricular hypertrophy (LVH).
From a recent cohort in Australia among type 1 DM 
patients10, the prevalence of  LVH alone was 9%, which 
is twice the prevalence in the general population; how-
ever, in our study, we found a higher prevalence up to 
19.3%. This could be explained by the high prevalence 
of  hypertension (62%), which was strongly associated 
with LVH in our study.
Valensi, in an African population, found LVH in 33.6% 
of  the study population17. The population he assessed 
had one or more CVD risk factors and used both rest 
echocardiography and myocardial scintigraphy which 
could have led to a higher prevalence compared to 
what we found. Piyush in a cohort among type 2 DM 
patients found LVH in 51% of  all patients10. The dif-
ference between his and our findings may be due to a 
long duration of  DM of  10 years in his study while our 
patient population was newly diagnosed. Furthermore, 
our patients were younger; mean age 46 years compared 
to Piyush’s cohort which had 61 years as their mean age.
Screening for left ventricular hypertrophy in patients 
with type 2 diabetes mellitus in the community revealed 
a prevalence of  up to 56%. This prevalence was much 
higher than what we found, possibly because our pa-
tient population was newly diagnosed and the duration 
of  DM was only 2 months23. In the former, patients 
had a minimum duration of  diabetes of  5 years. This 
may call for longitudinal studies to assess the burden 




We found a high prevalence of  systolic dysfunction at 
21.8% among newly diagnosed diabetic patients in this 
study. Majority of  these patients 37(84.1%)  had type 2 
DM. Piyush in Australia found a lower prevalence of  
systolic dysfunction among type 2 DM patients which 
was present in 5%10. This is greatly different from what 
we found yet patients in Australia were much older; 
mean age 65 compared to 46 and duration of  DM of  
10 years compared to 2 months in our study. This calls 
for more studies to clear the difference.
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 There is evidence of  high prevalence of  reduced LVEF 
in diabetic patients without known heart disease. In one 
study the prevalence of  reduced LVEF was 16.7%24, 
comparable to our findings. Valensi in an African popu-
lation found a lower prevalence of  systolic dysfunction 
of  3.2% compared to what we found. The reason for 
the difference could be the fact that all patients assessed 
had no clinical features of  heart failure in Valensi’s co-
hort17. In our study we did no clinical assessment.
We found that 27 (13.4%) of  all patients had combined 
systolic and diastolic dysfunction in our study. This 
finding is similar to what was found in a cohort in Aus-
tralia which found combined systolic and diastolic dys-




Regional wall abnormalities were present among 8 (4.0 
%) of  all the study participants in our study. In Africa, 
the findings have been similar to what earlier studies 
in the developed world have shown15,17,22. Valensi gen-
erated evidence from an African diabetic population: 
Rest echocardiography revealed that hypokinesia was 
found in 6.1% of  the study population17. This finding is 
comparable to what we revealed in this study. The slight 
difference may be due to the fact that in the former 
study, both rest echocardiography and myocardial scin-
tigraphy were used; hence a higher sensitivity. 
 
 
Factors associated with echocardiographic abnor-
malities among newly diagnosed diabetic patients 
at Mulago Hospital.
In this study, we found that traditional CVD risk factors 
such as advancing age, hypertension, obesity, increas-
ing waist circumference and type 2 DM were associated 
with an abnormal echocardiogram in newly diagnosed 
adult diabetic patients in Uganda (in the unadjusted 
model).
These findings are similar to what was found in other 
previous studies on echocardiographic abnormalities 
among diabetic patients10,14. The increasing prevalence 
of  factors like  hypertension and obesity has led to an 
increase in the risk and prevalence of  cardiac abnormal-
ities in DM25. This is in line with what we are seeing in 
this study.
We found a high burden of  hypertension at 62% among 
the study population. It was strongly associated with an 
abnormal echocardiogram in our study. This is in agree-
ment with earlier studies which described that hyper-
tension is more prevalent in diabetic patients in sub-Sa-
haran Africa26. The other reason which can explain this 
association is that: Individuals with hypertension are 
at increased risk of  DM compared with normotensive 
persons. Furthermore, up to 75% of  cases of  cardiac 
disease in DM  can be attributed to hypertension27.
Piyush, in a longitudinal study in Australia among type 
2 DM patients found the independent predictors of  an 
abnormal heart echocardiogram were obesity, age and 
the number of  antihypertensive agents used. Age was 
the strongest predictor of  an abnormal echocardio-
gram, with the risk increasing by 9% for each year over 
50 years of  age10. This is similar to what we found that 
every 1 year increase in age has a 9% increased odds of  
having an abnormal echocardiogram.
After multivariate adjustment, however, only age was 
independently associated with echocardiographic ab-
normalities among newly diagnosed diabetic patients. 
Life expectancy in sub-Saharan Africa; including Ugan-
da has risen in the past 50 years. Many more people 
living with DM are therefore exposed to the CVD risk 
factors for long periods for the cardiac complications 
to develop5.This may be the reason why age is an im-
portant factor in this study. In addition, advancing age 
is a known risk factor for diastolic dysfunction in the 
general population; this could have contributed to the 
high prevalence among the elderly.
Gough described that glycemic control does not affect 
cardiac abnormalities in the short term among diabetics 
26. We reached a similar conclusion in this study: glyce-
mic control was not associated with cardiac abnormal-
ities despite very profound hyperglycemic states, mean 
HbA1C was 13.4%.
Similarly microalbuminuria measured by urine ACR 
was not associated with an abnormal echocardiogram, 
despite the fact that significant microalbuminuria was 
present in 54% of  all patients. This is in contrast with 
the Strong Heart Study in diabetes, which found uri-
nary albumin excretion was independently associated 
with cardiac dysfunction28. In the later study ACR was 
measured at least twice but in our study only one meas-
urement was taken.
 
Limitation of  the study
We recognize that the lack of  an non diabetic control 
population is a limitation of  our study; however, this 
study was not designed to determine the effect of  di-
abetes on cardiac structure and function, but rather to 
African Health Sciences Vol 16 Issue 1, March 2016 191
explore the magnitude of  subclinical cardiac abnormal-
ities among newly diagnosed diabetic patients in the 
SSA context, including the risk associated with tradi-
tional CVD risk factors. Secondly, we used spot urine 
ACR as a single measure yet persistent microalbuminu-
ria would be diagnosed by at least 2 measurements de-
picting 20mg/g according to our laboratory. This was 
due to logistical limitations.
We measured diastolic dysfunction using mitral E/A 
ratios because it is the standard of  care in our setting. 
Although rigorous TDI in addition to E/A ratios from 
conventional Doppler studies was necessary to unmask 
pseudonormalization, it was not done due to lack of  ca-
pacity. This may result in missing up to 25% of  cases of  
diastolic dysfunction with pseudonormalization. There-
fore the prevalence of  diastolic dysfunction we are re-
porting may be an under estimate of  a bigger problem. 
Patients with clinical heart failure were not excluded 
and this may confound our findings because patients 
with heart failure may develop diabetes and conversely 
diabetics are at risk of  heart failure. This is one of  the 
limitations in this study.
We differentiated type1 and type 2 DM using clinical 
assessment because we could not assess insulin levels 
which is the gold standard: this is a limitation for this 
study.
We were unable to enroll the desired number of  partic-
ipants according to the sample size estimated. This was 
due to limitations in logistics for the required investiga-
tions.
Conclusion
Overall prevalence of  an abnormal echocardiogram 
among newly diagnosed diabetic patients was high at 
67.8% with majority having diastolic dysfunction as the 
main abnormality. Left ventricular hypertrophy, sys-
tolic dysfunction and regional wall abnormalities were 
common findings in this study. Traditional CVD risk 
factors including: Advancing age, hypertension, type 2 
DM, obesity and increasing waist circumference were 
associated with an abnormal echocardiogram in this 
population. Microalbuminuria, a known CVD risk fac-
tor measured using urine ACR was not associated with 
any of  the echocardiographic abnormalities despite a 
high prevalence at 54%. Similarly HbA1C, which is a 
measure of  glycemic control, was not associated with 
echocardiographic abnormalities although this patient 
population had profound hyperglycemic states: mean 
HbA1C was 13.4%.
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